Trials / Unknown
UnknownNCT03690076
Human Cardiac Mitochondria in Acute Endocarditis and Obesity
Development of the Purification of Human Cardiac Mitochondria, Characterization of These Organelles and Validation of the Model in Acute Endocarditis and Obesity
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Data about human cardiac mitochondria are cruelly lacking in the literature. However, damages of the activity of these organelles are often the source of abnormal cardiac function in several pathologies. The purpose of this study is to develop a model of purified human cardiac mitochondria, to verify the purity of these organelles and to validate the authenticity of their function in acute endocarditis and obesity, two situations known to alter their activity. Animal studies have shown that microbial infection reduced mitochondrial metabolism whereas obesity increases it. The investigator's hypotheses are the following: 1) acute endocarditis, a form of cardiac microbial infection, reduces the function of human cardiac mitochondria; 2) obesity (body mass index \> 30) activates the metabolism of human cardiac mitochondria.
Detailed description
3 groups of patients: * Controls: patients with normal weight (23 \< BMI \< 27) operated for myocardial revascularization by bypass surgery, without infarction, or for valve pathologies without endocarditis * Endocarditis: patients with normal weight (23 \< BMI \< 27) carriers of endocarditis with surgery indication * Obese: obese patients (BMI \> 30) operated for myocardial revascularization by bypass surgery, without infarction, or for valve pathologies without endocarditis Comparisons studied: * Controls vs. endocarditis * Controls vs. obese patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Endocarditis | Comparison : Endocarditis vs. control |
| OTHER | Obese vs. control | Comparisons : Obese vs. control |
Timeline
- Start date
- 2018-10-09
- Primary completion
- 2020-04-30
- Completion
- 2020-09-30
- First posted
- 2018-10-01
- Last updated
- 2019-02-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03690076. Inclusion in this directory is not an endorsement.